{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:27:34Z","timestamp":1779341254521,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020895","name":"Temerty Faculty of Medicine, University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004060","name":"Preeclampsia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jogc.2025.103073","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T07:26:43Z","timestamp":1755242803000},"page":"103073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patterns of Aspirin Non-Use by Preeclampsia Risk Factors in High-Risk Pregnancies: A Retrospective Cohort Study"],"prefix":"10.1016","volume":"47","author":[{"given":"Leonet B.","family":"Reid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary K.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria E.","family":"Rac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Kingdom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7128-8916","authenticated-orcid":false,"given":"John W.","family":"Snelgrove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2025.103073_bib1","doi-asserted-by":"crossref","first-page":"E897","DOI":"10.1503\/cmaj.231547","article-title":"Trends in rate of hypertensive disorders of pregnancy and associated morbidities in Canada: a population-based study (2012\u20132021)","volume":"196","author":"Dzakpasu","year":"2024","journal-title":"CMAJ"},{"key":"10.1016\/j.jogc.2025.103073_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046174","article-title":"Neighbourhood material deprivation and severe maternal morbidity: a population-based cohort study in Ontario, Canada","volume":"11","author":"Snelgrove","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jogc.2025.103073_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.4571","article-title":"Prevalence of severe maternal morbidity and factors associated with maternal mortality in ontario, canada","volume":"1","author":"Ray","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jogc.2025.103073_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2025.103073_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","article-title":"Guideline no. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management","volume":"44","author":"Magee","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2025.103073_bib6","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.2023.16991","article-title":"Screening for hypertensive disorders of pregnancy: US Preventive Services Task Force final recommendation statement","volume":"330","author":"Barry","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2025.103073_bib7","series-title":"Hypertension in pregnancy: diagnosis and management","year":"2019"},{"key":"10.1016\/j.jogc.2025.103073_bib8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jogc.2017.04.040","article-title":"Low rates of aspirin use for the prevention of preeclampsia","volume":"39","author":"Viguiliouk","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2025.103073_bib9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2021.22749","article-title":"Aspirin use for preeclampsia prevention among women with prepregnancy diabetes, obesity, and hypertension","volume":"327","author":"Ray","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2025.103073_bib10","doi-asserted-by":"crossref","first-page":"e2410","DOI":"10.1055\/s-0043-1771260","article-title":"Efficacy and safety of Aspirin 162 mg for preeclampsia prophylaxis in high-risk patients","volume":"41","author":"Ayyash","year":"2024","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jogc.2025.103073_bib11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1471-0528.2010.02507.x","article-title":"Clinical and geographical variation in prophylactic and therapeutic treatments for pre-eclampsia in the UK","volume":"117","author":"Chappell","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2025.103073_bib12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1186\/s12884-023-06039-w","article-title":"Missed opportunities in aspirin prescribing for preeclampsia prevention","volume":"23","author":"Singh","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jogc.2025.103073_bib13","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1161\/HYPERTENSIONAHA.121.17047","article-title":"PlGF (placental growth factor) testing in clinical practice: evidence from a Canadian tertiary maternity referral center","volume":"77","author":"McLaughlin","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jogc.2025.103073_bib14","article-title":"Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies","volume":"353","author":"Bartsch","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jogc.2025.103073_bib15","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00404-022-06773-0","article-title":"Relationship between risk factor profile and prescription of low-dose aspirin for preeclampsia prevention","volume":"308","author":"Phelps","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jogc.2025.103073_bib16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0040-1718580","article-title":"Improving utilization of aspirin for prevention of preeclampsia in a high-risk urban cohort: a prospective cohort study","volume":"38","author":"Boelig","year":"2021","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jogc.2025.103073_bib17","doi-asserted-by":"crossref","first-page":"E236","DOI":"10.9778\/cmajo.20140110","article-title":"Rates of prenatal screening across health care regions in Ontario, Canada: a retrospective cohort study","volume":"3","author":"Hayeems","year":"2015","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jogc.2025.103073_bib18","doi-asserted-by":"crossref","first-page":"199.e1","DOI":"10.1016\/j.ajog.2018.11.1087","article-title":"Predictive performance of the competing risk model in screening for preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2025.103073_bib19","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks' gestation: comparison with nice guidelines and ACOG recommendations","volume":"49","author":"O'Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2025.103073_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100815","article-title":"The implementation of preeclampsia screening and prevention (IMPRESS) study","volume":"5","author":"Johnson","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.jogc.2025.103073_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2023.102220","article-title":"Implementation of multiple marker screening for preterm preeclampsia in a single tertiary obstetric centre","volume":"46","author":"Okun","year":"2024","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2025.103073_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12884-025-07154-6","article-title":"Preterm preeclampsia screening and prevention: a comprehensive approach to implementation in a real-world setting","volume":"25","author":"Ronzoni","year":"2025","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jogc.2025.103073_bib23","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/AOG.0000000000001115","article-title":"A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States","volume":"126","author":"Werner","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2025.103073_bib24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jama.2023.0691","article-title":"Aspirin discontinuation at 24 to 28 weeks' gestation in pregnancies at high risk of preterm preeclampsia: a randomized clinical trial","volume":"329","author":"Mendoza","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2025.103073_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.30804","article-title":"Use of a smartphone app to explore potential underuse of prophylactic aspirin for preeclampsia","volume":"4","author":"Krishnamurti","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jogc.2025.103073_bib26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/21642850.2021.1951273","article-title":"Aspirin non-adherence in pregnant women at risk of preeclampsia (ANA): a qualitative study","volume":"9","author":"Vinogradov","year":"2021","journal-title":"Health Psychol Behav Med"},{"key":"10.1016\/j.jogc.2025.103073_bib27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1701-2163(15)30588-0","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary","volume":"36","author":"Magee","year":"2014","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216325003196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216325003196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:13:27Z","timestamp":1772892807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216325003196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1701216325003196"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2025.103073","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of Aspirin Non-Use by Preeclampsia Risk Factors in High-Risk Pregnancies: A Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2025.103073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier Inc. on behalf of The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada.","name":"copyright","label":"Copyright"}],"article-number":"103073"}}